C

China National Medicines Corp Ltd
SSE:600511

Watchlist Manager
China National Medicines Corp Ltd
SSE:600511
Watchlist
Price: 33.49 CNY -1.35%
Market Cap: 25.3B CNY
Have any thoughts about
China National Medicines Corp Ltd?
Write Note

Intrinsic Value

The intrinsic value of one China National Medicines Corp Ltd stock under the Base Case scenario is 60.97 CNY. Compared to the current market price of 33.49 CNY, China National Medicines Corp Ltd is Undervalued by 45%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
60.97 CNY
Undervaluation 45%
Intrinsic Value
Price
C
Worst Case
Base Case
Best Case

Valuation History
China National Medicines Corp Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for China National Medicines Corp Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about China National Medicines Corp Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Qualitative Analysis
China National Medicines Corp Ltd
CN
Health Care
Market Cap
25.3B CNY
IPO
Nov 27, 2002
Employees
3 005
China
Market Cap
25.3B CNY
Industry
Health Care
IPO
Nov 27, 2002
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about China National Medicines Corp Ltd

Provide an overview of the primary business activities
of China National Medicines Corp Ltd.

What unique competitive advantages
does China National Medicines Corp Ltd hold over its rivals?

What risks and challenges
does China National Medicines Corp Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for China National Medicines Corp Ltd.

Provide P/S
for China National Medicines Corp Ltd.

Provide P/E
for China National Medicines Corp Ltd.

Provide P/OCF
for China National Medicines Corp Ltd.

Provide P/FCFE
for China National Medicines Corp Ltd.

Provide P/B
for China National Medicines Corp Ltd.

Provide EV/S
for China National Medicines Corp Ltd.

Provide EV/GP
for China National Medicines Corp Ltd.

Provide EV/EBITDA
for China National Medicines Corp Ltd.

Provide EV/EBIT
for China National Medicines Corp Ltd.

Provide EV/OCF
for China National Medicines Corp Ltd.

Provide EV/FCFF
for China National Medicines Corp Ltd.

Provide EV/IC
for China National Medicines Corp Ltd.

Show me price targets
for China National Medicines Corp Ltd made by professional analysts.

What are the Revenue projections
for China National Medicines Corp Ltd?

How accurate were the past Revenue estimates
for China National Medicines Corp Ltd?

What are the Net Income projections
for China National Medicines Corp Ltd?

How accurate were the past Net Income estimates
for China National Medicines Corp Ltd?

What are the EPS projections
for China National Medicines Corp Ltd?

How accurate were the past EPS estimates
for China National Medicines Corp Ltd?

What are the EBIT projections
for China National Medicines Corp Ltd?

How accurate were the past EBIT estimates
for China National Medicines Corp Ltd?

Compare the revenue forecasts
for China National Medicines Corp Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of China National Medicines Corp Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of China National Medicines Corp Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of China National Medicines Corp Ltd compared to its peers.

Compare the P/E ratios
of China National Medicines Corp Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing China National Medicines Corp Ltd with its peers.

Analyze the financial leverage
of China National Medicines Corp Ltd compared to its main competitors.

Show all profitability ratios
for China National Medicines Corp Ltd.

Provide ROE
for China National Medicines Corp Ltd.

Provide ROA
for China National Medicines Corp Ltd.

Provide ROIC
for China National Medicines Corp Ltd.

Provide ROCE
for China National Medicines Corp Ltd.

Provide Gross Margin
for China National Medicines Corp Ltd.

Provide Operating Margin
for China National Medicines Corp Ltd.

Provide Net Margin
for China National Medicines Corp Ltd.

Provide FCF Margin
for China National Medicines Corp Ltd.

Show all solvency ratios
for China National Medicines Corp Ltd.

Provide D/E Ratio
for China National Medicines Corp Ltd.

Provide D/A Ratio
for China National Medicines Corp Ltd.

Provide Interest Coverage Ratio
for China National Medicines Corp Ltd.

Provide Altman Z-Score Ratio
for China National Medicines Corp Ltd.

Provide Quick Ratio
for China National Medicines Corp Ltd.

Provide Current Ratio
for China National Medicines Corp Ltd.

Provide Cash Ratio
for China National Medicines Corp Ltd.

What is the historical Revenue growth
over the last 5 years for China National Medicines Corp Ltd?

What is the historical Net Income growth
over the last 5 years for China National Medicines Corp Ltd?

What is the current Free Cash Flow
of China National Medicines Corp Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for China National Medicines Corp Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
China National Medicines Corp Ltd

Current Assets 29.2B
Cash & Short-Term Investments 8.5B
Receivables 15.5B
Other Current Assets 5.2B
Non-Current Assets 4.4B
Long-Term Investments 1.9B
PP&E 913.4m
Intangibles 597m
Other Non-Current Assets 914.9m
Current Liabilities 14.4B
Accounts Payable 9.3B
Accrued Liabilities 187.3m
Short-Term Debt 2.9B
Other Current Liabilities 2B
Non-Current Liabilities 3.1B
Long-Term Debt 281.2m
Other Non-Current Liabilities 2.8B
Efficiency

Earnings Waterfall
China National Medicines Corp Ltd

Revenue
51.2B CNY
Cost of Revenue
-47.5B CNY
Gross Profit
3.7B CNY
Operating Expenses
-1.3B CNY
Operating Income
2.4B CNY
Other Expenses
-234.1m CNY
Net Income
2.2B CNY

Free Cash Flow Analysis
China National Medicines Corp Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

China National Medicines Corp Ltd's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Positive 3-Year Average ROIC
Positive 3-Year Average ROE
Positive Free Cash Flow
Positive ROIC
52/100
Profitability
Score

China National Medicines Corp Ltd's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

China National Medicines Corp Ltd's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Low D/E
Negative Net Debt
High Altman Z-Score
Short-Term Solvency
68/100
Solvency
Score

China National Medicines Corp Ltd's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
China National Medicines Corp Ltd

Wall Street analysts forecast China National Medicines Corp Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for China National Medicines Corp Ltd is 45.05 CNY with a low forecast of 41.41 CNY and a high forecast of 49.98 CNY.

Lowest
Price Target
41.41 CNY
24% Upside
Average
Price Target
45.05 CNY
35% Upside
Highest
Price Target
49.98 CNY
49% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for China National Medicines Corp Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for China National Medicines Corp Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one China National Medicines Corp Ltd stock?

The intrinsic value of one China National Medicines Corp Ltd stock under the Base Case scenario is 60.97 CNY.

Is China National Medicines Corp Ltd stock undervalued or overvalued?

Compared to the current market price of 33.49 CNY, China National Medicines Corp Ltd is Undervalued by 45%.

Back to Top